Incidence

Incidence

Cancer incidence is typically measured as the number of new cases each year for every 100,000 people (for sex-specific cancers, people of the same sex serve as the denominator) and age-adjusted to a standard population to allow comparisons over time.

In 2022, nearly half of all new cancer cases are expected to be cancers of the prostate, breast, lung, and colon and rectum. According to American Cancer Society projections, about 1,918,030 new cases of cancer are expected to be diagnosed in 2022, including 268,490 cases of prostate cancer, 290,560 cases of breast cancer, 236,740 cases of lung and bronchus cancer, and 151,030 cases of colorectal cancer.

Incidence rate: the observed number of new cancer cases per 100,000 people per year, adjusted for age and cancer case reporting delays and based on data from approximately 10 percent of the U.S. population.

Delay adjustment: a method of estimating delayed reporting of incident cases and then adjusting rates to account for this delay.

SEER Program, National Cancer Institute, 1975–2019.

There are no Healthy People 2030 targets for cancer incidence.

Healthy People 2030 is a set of goals set forth by the Department of Health and Human Services.

1975-2019
2015-2019
Stable
Falling
Diagnosis